A recent UCLA study demonstrates a new process for screening T cells, part of the body's natural defenses, for characteristics vital to the success of cell-based treatments. The method filters T cells based on the receptor proteins found on their surface—which enable them to latch onto certain threats—and the type and amount of cell-killing or immune response-triggering molecules that they secrete. Read this story
